CNMD
CONMED Corporation
44.70$
-1.5%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 34.7% | 36.3% | 24.9% | 26.3% | 27.3% | 22.4% | 23.8% | 26.1% | 25.3% | 26.8% | 27.8% | 28.9% | |
| 6.0% | 6.5% | 2.1% | 2.4% | 1.3% | 1.5% | 1.6% | 1.2% | 1.3% | 1.1% | 1.1% | 1.8% | |
| 6.0% | 6.5% | 2.1% | 2.4% | 1.3% | 1.5% | 1.6% | 1.2% | 1.3% | 1.1% | 1.1% | 1.8% | |
| 11.8% | 12.0% | 11.2% | 12.3% | 13.3% | 10.7% | 10.1% | 10.4% | 8.3% | 10.5% | 10.3% | 10.7% | |
| 13.5% | 15.0% | 10.2% | 10.4% | 11.3% | 9.3% | 11.1% | 13.1% | 14.5% | 13.8% | 15.0% | 15.3% | |
| 12.1% | 11.3% | 9.2% | 8.6% | 8.3% | 6.7% | 6.4% | 6.2% | 5.0% | – | – | – | |
| 23.3% | 23.4% | 29.9% | 29.6% | 29.2% | 34.8% | 35.3% | 35.0% | 35.5% | 35.1% | 34.9% | 34.7% | |
| 28.8% | 27.7% | 31.6% | 30.6% | 30.2% | 30.0% | 28.6% | 26.7% | 29.7% | 28.2% | 26.8% | 25.0% | |
| 47.1% | 47.4% | 56.3% | 53.5% | 51.6% | 60.0% | 59.5% | 55.5% | 67.6% | 63.7% | 58.3% | 55.6% | |
| 10.6% | 10.8% | 8.6% | 11.0% | 11.8% | 10.6% | 10.9% | 11.1% | 12.9% | 13.5% | 12.1% | 13.5% | |
| 0.1% | 0.1% | 0.8% | 1.1% | 1.3% | 1.2% | 1.5% | 0.7% | 3.0% | 0.4% | 0.0% | 0.0% | |
| 2.2% | 3.1% | 3.1% | 3.1% | 3.9% | 3.2% | 3.0% | 3.3% | 3.2% | 3.8% | 4.4% | 4.0% | |
| 21.9% | 24.2% | 36.7% | 34.7% | 32.0% | 42.5% | 42.0% | 38.1% | 42.9% | 42.3% | 39.2% | 35.9% | |
| 52.9% | 52.6% | 43.7% | 46.5% | 48.4% | 40.0% | 40.5% | 44.5% | 32.4% | 36.3% | 41.7% | 44.4% | |
| 37.0% | 37.2% | 30.6% | 32.4% | 34.0% | 26.5% | 26.1% | 28.1% | 18.0% | 19.7% | 24.3% | 25.3% | |
| 2.5% | 2.5% | 2.1% | 2.1% | 2.1% | 1.7% | 1.7% | 1.8% | 1.3% | 1.4% | 1.3% | 1.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.